NICOX SA (COX.PA) Fundamental Analysis & Valuation

EPA:COX • FR0013018124

Current stock price

0.579 EUR
0 (-0.52%)
Last:

This COX.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. COX.PA Profitability Analysis

1.1 Basic Checks

  • COX had negative earnings in the past year.
COX.PA Yearly Net Income VS EBIT VS OCF VS FCFCOX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 -10M -20M -30M -40M

1.2 Ratios

  • COX has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
COX.PA Yearly ROA, ROE, ROICCOX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 -10 -20 -30 -40 -50

1.3 Margins

  • COX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
COX.PA Yearly Profit, Operating, Gross MarginsCOX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 -20K -40K -60K -80K -100K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. COX.PA Health Analysis

2.1 Basic Checks

  • COX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, COX has more shares outstanding
  • Compared to 1 year ago, COX has a worse debt to assets ratio.
COX.PA Yearly Shares OutstandingCOX.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M
COX.PA Yearly Total Debt VS Total AssetsCOX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M

2.2 Solvency

  • COX has an Altman-Z score of -8.19. This is a bad value and indicates that COX is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of COX (-8.19) is worse than 69.14% of its industry peers.
  • COX has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.47, COX is in line with its industry, outperforming 54.32% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF N/A
Altman-Z -8.19
ROIC/WACCN/A
WACC6.99%
COX.PA Yearly LT Debt VS Equity VS FCFCOX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 50M 100M

2.3 Liquidity

  • A Current Ratio of 4.10 indicates that COX has no problem at all paying its short term obligations.
  • COX has a better Current ratio (4.10) than 75.31% of its industry peers.
  • A Quick Ratio of 4.10 indicates that COX has no problem at all paying its short term obligations.
  • The Quick ratio of COX (4.10) is better than 79.01% of its industry peers.
Industry RankSector Rank
Current Ratio 4.1
Quick Ratio 4.1
COX.PA Yearly Current Assets VS Current LiabilitesCOX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. COX.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 47.58% over the past year.
  • COX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -54.78%.
  • Measured over the past years, COX shows a small growth in Revenue. The Revenue has been growing by 7.25% on average per year.
EPS 1Y (TTM)47.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%74.55%
Revenue 1Y (TTM)-54.78%
Revenue growth 3Y-21.86%
Revenue growth 5Y7.25%
Sales Q2Q%-68.85%

3.2 Future

  • COX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.12% yearly.
  • The Revenue is expected to grow by 7.81% on average over the next years.
EPS Next Y35.92%
EPS Next 2Y9.12%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year16.23%
Revenue Next 2Y7.81%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
COX.PA Yearly Revenue VS EstimatesCOX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
COX.PA Yearly EPS VS EstimatesCOX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

Find the best growth stocksShow best growing peers

0

4. COX.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for COX. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for COX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
COX.PA Price Earnings VS Forward Price EarningsCOX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
COX.PA Per share dataCOX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y9.12%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. COX.PA Dividend Analysis

5.1 Amount

  • COX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

COX.PA Fundamentals: All Metrics, Ratios and Statistics

NICOX SA

EPA:COX (4/27/2023, 7:00:00 PM)

0.579

0 (-0.52%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap28.92M
Revenue(TTM)3.27M
Net Income(TTM)-27.76M
Analysts85
Price Target2.91 (402.59%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-46.73%
PT rev (3m)-46.73%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.92%
EPS NY rev (3m)10.56%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.25%
Revenue NY rev (3m)1.16%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.84
P/FCF N/A
P/OCF N/A
P/B 0.55
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.61
EYN/A
EPS(NY)-0.33
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.07
BVpS1.05
TBVpS-0.13
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score0
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.1
Quick Ratio 4.1
Altman-Z -8.19
F-Score0
WACC6.99%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)47.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%74.55%
EPS Next Y35.92%
EPS Next 2Y9.12%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-54.78%
Revenue growth 3Y-21.86%
Revenue growth 5Y7.25%
Sales Q2Q%-68.85%
Revenue Next Year16.23%
Revenue Next 2Y7.81%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-27.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year63.37%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

NICOX SA / COX.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of NICOX SA (COX.PA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to COX.PA.


What is the valuation status of NICOX SA (COX.PA) stock?

ChartMill assigns a valuation rating of 3 / 10 to NICOX SA (COX.PA). This can be considered as Overvalued.


Can you provide the profitability details for NICOX SA?

NICOX SA (COX.PA) has a profitability rating of 0 / 10.


What is the financial health of NICOX SA (COX.PA) stock?

The financial health rating of NICOX SA (COX.PA) is 3 / 10.